Wegovy vs Ozempic: What's the difference and which is best for you?

If you’ve been researching options for weight loss treatments, you may have come across medicines like Wegovy and Ozempic. They’re both GLP-1 medications, which mimic a natural hormone found in your stomach that regulates appetite and fullness.

But, while they contain the same active ingredient, semaglutide, they’re not identical treatments. Each is prescribed under different guidelines, because they are approved for different conditions.

If you’re wondering which is right for you, this guide will help you understand the differences between Wegovy and Ozempic, and how to choose the most appropriate option for your goals.

Article summary

• Wegovy and Ozempic both contain semaglutide, but they’re prescribed for different reasons. Wegovy is licensed for weight management, combined with a reduced-calorie diet and exercise, while Ozempic is licensed for type 2 diabetes.
• Wegovy comes as a daily pill or a weekly injection. Ozempic is also a weekly injection. All three can cause similar digestive side effects, including nausea, vomiting and diarrhoea.
• The right treatment depends on your health, goals and other medications. Understanding the differences between them will help you decide which to request, and a qualified healthcare professional can check that it’s safe and suitable for you.

Wegovy vs Ozempic: Key differences

What are the main differences between Wegovy and Ozempic?

Both Wegovy and Ozempic can have similar outcomes, but they’re designed for different primary purposes and so have different prescribing guidelines.

Wegovy has been specifically approved as a weight loss treatment, however, Ozempic is still only approved as a treatment for type 2 diabetes, though it may be considered off-label for weight management at the discretion of the prescriber. [1]

Another key difference is in the dosing. Wegovy is available in higher doses of semaglutide (up to 2.4mg weekly) compared to Ozempic (up to 2mg weekly), which may be an explanation for the potential difference in weight loss outcomes, but this has not been established by a head-to-head trial.

What are the main similarities between Wegovy and Ozempic?

Although they’re prescribed for different reasons, these treatments still have a few things in common:

• Both medications are taken once weekly via subcutaneous injection (meaning just under the skin), starting at a low dose that gradually increases over time. Wegovy is also available in pill form.
• Side effects are common when using semaglutide injections or tablets, and these are similar between Wegovy and Ozempic (typically nausea, diarrhoea, and vomiting). They can usually be managed by a low initial starting dose that’s increased gradually over time.
• Both treatments are intended for long-term use. Wegovy may be discontinued once a healthy weight is achieved, whereas Ozempic is often used as a longer-term or permanent part of diabetes management.

What is the common ingredient, semaglutide?

Both Wegovy and Ozempic are branded medications containing the same active ingredient: semaglutide. Semaglutide is a synthetic version of a natural hormone called GLP-1 (glucagon-like peptide-1). This hormone helps regulate blood sugar and appetite.

Semaglutide is delivered via weekly subcutaneous injections or daily if you’re taking the Wegovy Pill. [2]

This medication belongs to a class of drugs called GLP-1s, which are prescribed to help manage weight and type 2 diabetes.

Wegovy vs Ozempic dosage comparison

Both treatments are prescribed with careful dosing schedules. This involves starting with a lower dose that is usually gradually increased over time to reduce side effects and ensure safe, effective results.

Note: Dosing schedules serve as a guideline for the minimum amount of time between each dose increase. How your treatment progresses will mostly be determined by how your body responds to the medication (i.e. weight lost and tolerance for side effects). Everyone’s journey is different, and you don’t have to increase your dose if you don’t want to.

Wegovy injection dosing

• Administered once weekly as an under-the-skin injection in either the back of your upper arm, upper thigh or abdomen.
• Starting dose of 0.25mg weekly, which can be gradually increased to 2.4mg as long as the medication is well tolerated. [4]

Wegovy Pill dosing

• Taken orally on an empty stomach 30 minutes before food, coffee or any other drink or medication. You can use no more than half a glass of water (roughly 120ml) to help swallow the tablet.
• Starting dose of 1.5mg daily, which can be gradually increased. [3]

Ozempic dosing

• Administered once weekly as an under-the-skin injection in either the back of your upper arm, upper thigh or abdomen.
• Starting dose of 0.25mg weekly, which is typically increased to 1-2mg as long as the medication is well tolerated. [4]

Note: The dosing amounts mean that some people mistakenly believe that the Wegovy pills are six times stronger than the injection, but that’s not the case. When semaglutide is injected, almost all of it reaches your bloodstream. When you swallow it as a tablet, most of it is broken down in your stomach before it can be absorbed. Only a small amount gets through. To make up for this, the tablet contains a much larger dose, so the numbers can't be compared directly.

Wegovy vs Ozempic cost

Although Wegovy and Ozempic are generally similar in price, in the UK, the price of any GLP-1 medication varies depending on the pharmacy, availability of the drug (which can change over time), and whether you’re being prescribed it privately or via the NHS.

How do the results differ between Wegovy and Ozempic?

Both Wegovy and Ozempic are proven to help with weight loss to different degrees, though Wegovy has been specifically designed and researched for this purpose. GLP-1 medications like semaglutide work best when combined with healthy lifestyle changes.

Both medications have been widely studied in clinical research. A major clinical trial found that people with obesity using 7.2mg of Wegovy weekly lost an average of 20.7% of their body weight over 72 weeks. [5] Another study showed that people with type 2 diabetes using 1mg of Ozempic weekly lost around 5-7% of their body weight over 104 weeks. [6]

Wegovy vs Ozempic eligibility

It’s important that a licensed healthcare professional reviews your medical history to decide whether semaglutide treatments are safe for you to use. This will depend on any underlying health conditions, current medications, and overall risk profile. Both Wegovy and Ozempic are designed for those focused on long-term results and management of their conditions.

Every case must be reviewed by a pharmacist, but in general, Wegovy can be prescribed to adults with obesity with a body mass index (BMI) over 30, or a BMI over 27 if you also have a weight-related health condition. However, NHS prescribing guidelines may differ to private providers. [7]

Ozempic should only be prescribed as a treatment for adults with type 2 diabetes, and not as a weight loss medication. Your clinician will determine if Ozempic is safe and suitable for you.

Wegovy vs Ozempic side effects

Serious side effects are rare, but you should seek urgent medical help if you experience severe or persistent stomach pain (especially if it spreads to your back), repeated diarrhoea or vomiting, signs of dehydration, or allergy symptoms such as breathlessness or swelling of your mouth, lips or tongue. [3] [4] [5]

Wegovy vs Ozempic drug interactions

Taking other medicines doesn’t always rule out treatment, but it’s important to tell your prescribing pharmacist about everything you take, including supplements, contraception and medicines bought without a prescription. They can check whether you need extra support or a dose adjustment.

Can I switch between Wegovy and Ozempic?

Wegovy and Ozempic both contain semaglutide, but that doesn’t mean that you can just switch between the two.

It may be possible to switch from Ozempic to Wegovy if your goal is dedicated weight management, as the medication should control your blood sugar levels while also supporting your weight loss goals. Your clinician will decide your Wegovy starting dose based on your current Ozempic dose, side effects and blood sugar control.

However, unless you develop type 2 diabetes, you won’t need to consider switching from Wegovy to Ozempic.

Switching should always be done under medical supervision, with proper monitoring of dose changes, side effects, and treatment outcomes. Do not use both medicines at the same time, and do not swap doses yourself. Overlapping them could increase your risk of side effects, including low blood sugar, especially if you take insulin or a sulfonylurea.

How to choose between Wegovy and Ozempic

Whether you take Wegovy or Ozempic will primarily depend on your eligibility. If you’re specifically looking to focus on weight loss or management (and you don’t have type 2 diabetes) you will only be eligible for Wegovy. You could choose between the traditional Wegovy injection for weekly doses, or opt for the Wegovy Pill if daily tablets fit better into your routine.

If you have type 2 diabetes, weight loss isn’t your main goal and you feel comfortable with needles, then you may be prescribed Ozempic to help control your blood sugar levels.

The final verdict: Wegovy vs Ozempic

While Wegovy and Ozempic both contain semaglutide, they are prescribed for different purposes. This means that your treatment plan will be determined by whether you are looking to lose weight, or to get your diabetes under control.

At MedExpress, we offer online consultations with regular clinical check-ins, and a range of weight loss treatments including Mounjaro, Wegovy Pen, Wegovy Pill and Foundayo our team can help you find the right treatment for you.

References

1. Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine [Internet]. 2016 Nov 10 [cited 2026 Oct 16];375(19):1834–44. Available from: https://www.nejm.org/doi/10.1056/NEJMoa1607141?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov
2. Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, et al. Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism [Internet]. 2017 May 5;19(9):1242–51. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573908/
3. Wegovy 25 mg tablets (Reference only - not currently marketed in the UK) - Patient Information Leaflet (PIL) - (emc) | 102347 [Internet]. Medicines.org.uk. 2025 [cited 2026 Oct 15]. Available from: https://www.medicines.org.uk/emc/product/102347/pil
4. Wegovy 7.2 mg Solution for injection in pre-filled pen - Patient Information Leaflet (PIL) - (emc) | 102093 [Internet]. Medicines.org.uk. 2025 [cited 2026 Oct 15]. Available from: https://www.medicines.org.uk/emc/product/102093/pil
5. Ozempic 0.5 mg solution for injection in pre-filled pen - Patient Information Leaflet (PIL) - (emc) [Internet]. Medicines.org.uk. 2024 [cited 2026 Oct 15]. Available from: https://www.medicines.org.uk/emc/product/9750/pil
6. Wharton S, Freitas P, Hjelmesæth J, Kabisch M, Kandler K, Lingvay I, et al. Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. The Lancet Diabetes & Endocrinology [Internet]. 2025 Nov [cited 2026 Oct 16];13(11):949–63. Available from: https://www.thelancet.com/article/S2213-8587(25)00226-8/fulltext
7. Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine [Internet]. 2016 Nov 10 [cited 2026 Oct 16];375(19):1834–44. Available from: https://www.nejm.org/doi/10.1056/NEJMoa1607141?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov